Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial

Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial

Background: Chloroquine (CQ)-resistant Plasmodium vivax is increasingly reported throughout southeast Asia. The efficacy of CQ and alternative artemisinin combination therapies (ACTs) for vivax malaria in Malaysia is unknown. Methods: A randomized, controlled trial of CQ vs artesunate-mefloquine (AS...

Full description

Bibliographic Details
Main Authors: Grigg, Matthew J., William, Timothy, Menon, Jayaram, Barber, Bridget E., Wilkes, Christopher S., Rajahram, Giri S., Edstein, Michael D., Auburn, Sarah, Price, Ric N., Yeo, Tsin W., Yeo, Tsin Wen, Anstey, Nicholas M.
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Journal Article
Language:English
Published: 2016
Subjects:
Plasmodium vivax
Malaria
Online Access:https://hdl.handle.net/10356/83425
http://hdl.handle.net/10220/41420

Internet

https://hdl.handle.net/10356/83425
http://hdl.handle.net/10220/41420

Similar Items